Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Multifunctional Nanomaterials for Cancer Theranostics 257

hepatic tumor via RGD modified ultra­small Fe3O4 nanoprobes.

Theranostics 6 , 1780–1791 (2016).

39. Zhang X, Zheng Y, Wang Z, Huang S, Chen Y, Jiang W, Zhang H,
    Ding M, Li Q, Xiao X, Luo X, Wang Z, Qi H. Methotrexate­loaded
    PLGA nanobubbles for ultrasound imaging and synergistic targeted
    therapy of residual tumor during HIFU ablation. Biomaterials 35 ,
    5148–5161 (2014).


40. Shi J, Wang L, Zhang J, Ma R, Gao J, Liu Y, Zhang C, Zhang Z.
    A tumor­targeting near­infrared laser­triggered drug delivery system
    based on GO@Ag nanoparticles for chemo­photothermal therapy and
    X­ray imaging. Biomaterials 35 , 5847–5861 (2014).


41. Owens EA, Henary M, Ei Fakhri G, Choi HS. Tissue­specific
    near­infrared fluorescence imaging. Acc. Chem. Res. 49 , 1731–1740
    (2016).


42. Zhang P, Hu C, Ran W, Meng J, Yin Q, Li Y. Recent progress in light­
    triggered nanotheranostics for cancer treatment. Theranostics 6 ,
    948–968 (2016).


43. Jo SD, Ku SH, Won YY, Kim SH, Kwon IC. Targeted nanotheranostics
    for future personalized medicine: Recent progress in cancer therapy.
    Theranostics 6 , 1362–1377 (2016).


44. Kunjachan S, Ehling J, Storm G, Kiessling F, Lammers T. Noninvasive
    imaging of nanomedicines and nanotheranostics: Principles, progress,
    and prospects. Chem. Rev. 115 , 10907–10937 (2015).


45. Hu B, Dai F, Fan Z, Ma G, Tang Q, Zhang X. Nanotheranostics:
    Congo red/rutin­MNPs with enhanced magnetic resonance imaging
    and H2O2­responsive therapy of alzheimer’s disease in APPswe/
    PS1dE9 transgenic mice. Adv. Mater. 27 , 5499–5505 (2015).


46. Sharma S. Nanotheranostics in evidence based personalized medicine.
    Curr. Drug Targets 15 , 915–930 (2014).


47. Muthu MS, Leong DT, Mei L, Feng SS. Nanotheranostics — applica­
    tion and further development of nanomedicine strategies for advanced
    theranostics. Theranostics 4 , 660–677 (2014).


48. Mura S, Couvreur P. Nanotheranostics for personalized medicine. Adv.
    Drug Deliv. Rev. 64 , 1394–1416 (2012).


49. Snyderman R, Meade C, Drake C. Value of Personalized medicine.
    JAMA 315 , 613 (2016).


50. Muthu MS, Mei L, Feng SS. Nanotheranostics: Advanced nanomedi­
    cine for the integration of diagnosis and therapy. Nanomedicine 9 ,
    1277–1280 (2014).